Pyk2-deficiency Potentiates Osteoblast Differentiation and Mineralizing Activity in Response to Estrogen and Raloxifene

Bone remodeling is controlled by the actions of bone-degrading osteoclasts and bone-forming osteoblasts (OBs). Aging and loss of estrogen after menopause affect bone mass and quality. Estrogen therapy, including selective estrogen receptor modulators (SERMs), can prevent bone loss and increase bone...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cell Endocrinol
Main Authors: Posritong, Sumana, Hong, Jung Min, Eleniste, Pierre P., McIntyre, Patrick W., Wu, Jennifer L., Himes, Evan R., Patel, Vruti, Kacena, Melissa A., Bruzzaniti, Angela
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6057828/
https://ncbi.nlm.nih.gov/pubmed/29428397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2018.02.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados